Patent · US Expired

Papillomavirus polyprotein constructs

US6365160B1 · kind B1 · utility

16Cited by
2References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 21, 1998
Grant dateApr 2, 2002
Priority date
Expiry dateApr 21, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/20022
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Peptides, antibodies and recombinant expression systems or cells that contain and express a DNA insert of HPV encoding a region of a papilloma induced or a papilloma protein, such as E6 or E7, are produced. Compositions containing these peptides, antibodies and/or recombinant cells are utilized as immunogenic compositions and in methods for inhibiting and treating HPV infection and tumor initiation and progression. Specific peptides and recombinant cells, such as vaccinia virus and tumor cells, that express epitopic regions of the HPV16 E6 or E7 nucleoprotein are particularly described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.